REFRESH TEARS PF- carboxymethylcellulose sodium, glycerin solution/ drops 
Allergan, Inc.

----------

REFRESH TEARS PF
Drug Facts

Active ingredients

Carboxymethylcellulose sodium 0.5%

Glycerin 0.9%

Purpose

Eye lubricant

Eye lubricant

Uses

Warnings

Stop use and ask a doctor if

you experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Other information

Inactive ingredients

Boric acid; calcium chloride dihydrate; erythritol; levocarnitine; magnesium chloride hexahydrate; potassium chloride; purified water; sodium borate decahydrate; and sodium citrate dihydrate.

Questions or comments?

1.800.678.1605

refresheyedrops.com

v1.0DFL1101

PRINCIPAL DISPLAY PANEL

NDC 0023-3110-10

NEW & IMPROVED

PRESERVATIVE-FREE

Refresh
Tears® PF
Lubricating Eye Drops

PRINCIPAL DISPLAY PANEL
NDC 0023-3110-10
NEW & IMPROVED
PRESERVATIVE-FREE
Refresh
Tears® PF
Lubricating Eye Drops

REFRESH TEARS PF 
carboxymethylcellulose sodium, glycerin solution/ drops
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0023-3110
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CARBOXYMETHYLCELLULOSE SODIUM (UNII: K679OBS311) (CARBOXYMETHYLCELLULOSE - UNII:05JZI7B19X) CARBOXYMETHYLCELLULOSE SODIUM5 mg  in 1 mL
GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) GLYCERIN9 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
BORIC ACID (UNII: R57ZHV85D4)  
CALCIUM CHLORIDE (UNII: M4I0D6VV5M)  
ERYTHRITOL (UNII: RA96B954X6)  
LEVOCARNITINE (UNII: 0G389FZZ9M)  
MAGNESIUM CHLORIDE (UNII: 02F3473H9O)  
POTASSIUM CHLORIDE (UNII: 660YQ98I10)  
WATER (UNII: 059QF0KO0R)  
SODIUM BORATE (UNII: 91MBZ8H3QO)  
TRISODIUM CITRATE DIHYDRATE (UNII: B22547B95K)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0023-3110-101 in 1 CARTON03/01/2024
110 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
2NDC:0023-3110-351 in 1 CARTON03/01/2024
210 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
3NDC:0023-3110-501 in 1 CARTON03/01/2024
33.5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01803/01/2024
Labeler - Allergan, Inc. (144796497)

Revised: 3/2024
Document Id: d36a6b6a-e747-4498-ac8b-5f3c5b773880
Set id: 9e1cba7b-84ed-47f3-b19a-121992834350
Version: 2
Effective Time: 20240301
 
Allergan, Inc.